Forecast lowered as Merck sales fall
Posted: October 29, 2013 at 3:56 a.m.
Merck & Co., the second-biggest U.S. drugmaker, reported a profit that beat analyst estimates after sales of the vaccine Gardasil and rheumatoid arthritis medicine Remicade rose, but the company narrowed its 2013 profit forecast.
This story is only available from our archives.
Business, Pages 23 on 10/29/2013